The pathological hallmark of AD is the extracellular deposition of beta amyloid peptide (Aβ), the oligomeric soluble forms of which are believed to be a key point for neuronal dysfunction, synapse loss, neurofibrillary degeneration (Das et al., 2016). Here, APP is linked to Alzheimer disease.